Feb 17, 2026 05:31PM
Sep 30, 2025 05:23PM
Sep 30, 2025 05:23PM
Aug 11, 2025 01:20AM
Jul 31, 2025 04:30PM
Jul 31, 2025 04:30PM
Mar 20, 2025 07:40PM Novartis receives third FDA approval for oral Fabhalta
Mar 20, 2025 07:37PM
Feb 18, 2025 09:00AM
Nov 5, 2024 07:05AM
Oct 28, 2024 04:44PM
Oct 26, 2024 07:50PM
May 25, 2024 06:00AM
Apr 17, 2024 01:20AM Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment-naïve people with relapsing multiple sclerosis
Feb 25, 2024 02:00PM
Feb 16, 2024 11:20AM
Jan 5, 2024 09:23AM
Dec 10, 2023 07:39PM
Dec 6, 2023 12:18AM
Dec 5, 2023 07:16PM
Nov 24, 2023 10:00AM Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization
Oct 6, 2023 04:20PM
Sep 11, 2023 10:01AM
Sep 11, 2023 10:00AM
Aug 8, 2023 04:01PM
Jul 17, 2023 09:00AM
Jul 17, 2023 08:59AM
Jul 17, 2023 08:46AM Novan (NOVN) to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection
Jul 17, 2023 08:45AM
Jul 12, 2023 07:30AM
Jul 10, 2023 07:16AM
Jul 10, 2023 07:15AM
Jun 8, 2023 07:00AM
Jun 5, 2023 09:00AM
Jun 5, 2023 09:00AM Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
Jun 1, 2023 08:24AM
May 31, 2023 04:08PM
May 31, 2023 04:05PM
May 15, 2023 06:45AM
May 8, 2023 09:05AM
May 4, 2023 04:01PM
Apr 27, 2023 09:13AM Novan (NOVN) Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement
Apr 27, 2023 09:10AM
Apr 27, 2023 09:10AM
Apr 20, 2023 09:00AM
Apr 20, 2023 09:00AM
Mar 30, 2023 06:32AM
Mar 30, 2023 06:30AM
Mar 30, 2023 06:30AM Novan Reports Full Year 2022 Financial Results and Provides Corporate Update
Mar 27, 2023 01:20AM

322,093 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All